Searched for
AJANTA PHARMA STOCKS
Sunil Singhania-backed Abakkus Flexi Cap Fund increases stake in HDFC Bank, RIL and 29 others in MaySunil Singhania-backed Abakkus Flexi Cap Fund significantly increased its holdings in HDFC Bank and Reliance Industries during May. The fun...- PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ahead of Market: 10 things that will decide stock market action on ThursdayDomestic equity benchmarks ended marginally higher after four sessions of losses, supported by gains in metal, energy and consumer stocks. ...
- Vodafone Idea and 4 other midcap stocks hit 52-week highs, rally up to 40% in a monthBenchmark indices ended marginally higher as five BSE 150 Midcap stocks touched fresh 52-week highs, reflecting strong investor sentiment a...
- Stock Radar: 50% rally in 6 months! This pharma stock gave a breakout from a bullish Flag pattern; time to buy?Ajanta Pharma Ltd's stock experienced mild consolidation in August but has since regained momentum, breaking above the Flag pattern. Expert...
- Buy Ajanta Pharma, target price Rs 2030: ICICI SecuritiesAjanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the yea...
- Buy Ajanta Pharma, target price Rs 1580: ICICI SecuritiesAjanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 18277.05 Crore) operating in Pharmaceuticals ...
- This smallcap pharma company declares 350% interim dividend; record date fixedPayment of interim dividend of Rs 7/- (350%) per equity share on the face-value of Rs 2/- per share for the Financial Year 2022-23,” said t...
- Buy Ajanta Pharma, target price Rs 1495: ICICI DirectAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16369.91 Crore) operating in Pharmaceuti...
- Buy Ajanta Pharma, target price Rs 1495: ICICI DirectAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16207.83 Crore) operating in Pharmaceuti...
- Ajanta Pharma board approves up to Rs 286-crore share buyback planThe total pay-out towards buyback of shares will be not exceeding Rs 356 crore, including a share buyback consideration not exceeding Rs 28...
- Ajanta Pharma Q2 results: Profit up 15% at Rs 196 croreRevenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...
- Ajanta Pharma launches generic asthma treatment tablets in USAjanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American marke...
- Stock Buzz: Ajanta Pharma set to benefit from the US upsideIt has been a dream year for Ajanta Pharma but this dream year got over two months ago when Ajanta Pharma hit a new life high of about Rs 1...
Load More
